Abstract AT1 receptor is an interesting biological target involved in several important diseases, such as blood hypertension and cardiovascular pathologies. In this study we investigated the main electrostatic and steric features of a series of AT1 antagonists related to hypertensive activity using structure and ligand-based strategies (docking and CoMFA). The generated 3D model had good internal and external consistency and was used to predict the potency of an external test set. The predicted values of pIC50 are in good agreement with the experimental results of biological activity, indicating that the 3D model can be used to predict the biological property of untested compounds. The electrostatic and steric CoMFA maps showed molecular recognition patterns, which were analyzed with structure-based molecular modeling studies (docking). The most and the least potent compounds docked into the AT1 binding site were subjected to molecular dynamics simulations with the aim to verify the stability and the flexibility of the ligand-receptor interactions. These results provided valuable insights on the electronic/structural requirements to design novel AT1 antagonists.
antagonists         0.9999999999996589^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Receptor_antagonist   

antagonists                   0.9999999999996589^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Receptor_antagonist   

3D model                      0.9999999904363222^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Computer_simulation   

molecular dynamics            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

hypertension                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hypertension          

AT1                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Angiotensin_II_receptor_type_1

cardiovascular                0.9957158466501033^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Circulatory_system    

pathologies                   0.8169450023440507^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pathology             

biological activity           0.87068646430544^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Biological_activity   

pIC50                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/IC50                  

AT1                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Angiotensin_II_receptor_type_1

biological target             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Biological_target     

hypertensive                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hypertension          

binding site                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Binding_site          

3D model                      0.9999999904363222^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Computer_simulation   

electrostatic                 0.9959179198939905^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electrostatics        

blood                         0.6041168148444518^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Blood_plasma          

molecular recognition         0.9999999992045332^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Molecular_recognition 

steric                        0.9984983914697374^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Steric_effects        

molecular modeling            0.9994247447860531^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Molecular_modelling   

steric                        0.9984983914697374^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Steric_effects        

AT1                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Angiotensin_II_receptor_type_1

electronic                    0.9999745976297187^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electron              

receptor                      0.999999999895067^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Receptor_(biochemistry)

electrostatic                 0.9959179198939905^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electrostatics        

potency                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Potency_(pharmacology)

AT1                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Angiotensin_II_receptor_type_1

